Helicobacter pylori infection.
Conditions
Interventions
Intervention 1: Intervention group: In this group, in addition to the standard and routine treatment , which includes two antibiotics (amoxicillin one gram twice a day and clarithromycin five hundred
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to 75 Years
Inclusion criteria
Inclusion criteria: Have Helicobacter pylori The patient volunteering to participate in the study, Age 40-75 years Be a resident of Arak.
Exclusion criteria
Exclusion criteria: Having a metastatic cancer Pregnancy Breastfeeding History of failure of previous H.PYLORI treatment Incomplete prescribed treatment regimen Irregular use of medications and non-adherence to the prescribed treatment regimen Previous gastrectomy Suffering from incurable diseases Patients with IHD Chronic renal failure GI bleeding Malignancy Concomitant use of tetracycline, quinolone, bisphosphonates, and levothyroxine (drug interaction) People undergoing chemotherapy Short Bowel Syndrome Anemia and neutropenia fever History of drug and food allergies Hypercalcemia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Helicobacter pylori infection using fecal antigen test. Timepoint: At the beginning of the study and 4 weeks after the intervention. Method of measurement: Stool antigen test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZahra Hashemi
Arak University of Medical Sciences
Outcome results
None listed